Similarly, SOD2 expression was positively correlated with M2 macrophage infiltration in patients with basal-like aggressive breast carcinoma (p < 0.001) (Fig. 6F), as validated by TIMER 2.0 [34], a systematic analysis of tumor-infiltrating immune cells. The gene discussed is SOD2; the disease is neoplasm.